Cargando…
Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
Autoimmune hemolytic anemia (AIHA) is a rare disease in which autoantibodies target red blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-threatening hemolysis. Little is known about the severity of anemia, blood transfusion efficiency and risk of transfusion-related...
Autores principales: | Chen, Chunxia, Wang, Lixin, Han, Bing, Qin, Li, Ying, Binwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959959/ https://www.ncbi.nlm.nih.gov/pubmed/31914091 http://dx.doi.org/10.1097/MD.0000000000018739 |
Ejemplares similares
-
Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022) -
Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study
por: Zhou, Ji-cheng, et al.
Publicado: (2020) -
Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report
por: Li, Xiang, et al.
Publicado: (2020) -
Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
por: Chang, Tsung-Yen, et al.
Publicado: (2016) -
Fatal fulminant hemolysis-associated pulmonary embolism in mixed-type autoimmune hemolytic anemia: A case report
por: Imataki, Osamu, et al.
Publicado: (2020)